A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma

Article ID	Journal	Published Year	Pages	File Type
6241820	Respiratory Medicine	2015	11 Pages	PDF

Abstract

NCT01641692.

Keywords

tmax UMEC LLQ Ventricular premature depolarization ULN SAE GCP INR ICS PEF ALT VPD FEV1 Cmax AUC LAMA Asthma Alanine aminotransferase long-acting muscarinic antagonist Muscarinic antagonist electrocardiogram ECG standard deviation Premature ventricular contraction bpm Chronic obstructive pulmonary disease COPD Fixed-dose combination Peak expiratory flow forced expiratory volume in one second Upper limit of normal lower limit of quantification maximum plasma concentration standard error Not available twice daily time to maximum plasma concentration beats per minute adverse event good clinical practice Serious adverse event pharmacokinetic confidence interval not determined ICH area under the curve International Normalized Ratio weighted mean PVC BID Least squares International Conference on Harmonisation Inhaled corticosteroid once daily

Related Topics

Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine

A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma

Authors

Laurie A. Lee, Anne Briggs, Lisa D. Edwards, Shuying Yang, Steven Pascoe,